Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Erythroid-specific human factor IX delivery from in vivo selected hematopoietic stem cells following nonmyeloablative conditioning in hemophilia B mice.

Chang AH, Stephan MT, Lisowski L, Sadelain M.

Mol Ther. 2008 Oct;16(10):1745-52. doi: 10.1038/mt.2008.161. Epub 2008 Aug 5.

2.

Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.

Schambach A, Baum C.

DNA Repair (Amst). 2007 Aug 1;6(8):1187-96. Epub 2007 May 7. Review.

3.

Supplying clotting factors from hematopoietic stem cell-derived erythroid and megakaryocytic lineage cells.

Sadelain M, Chang A, Lisowski L.

Mol Ther. 2009 Dec;17(12):1994-9. doi: 10.1038/mt.2009.238. Epub 2009 Oct 20. Review.

4.

Live and let die: in vivo selection of gene-modified hematopoietic stem cells via MGMT-mediated chemoprotection.

Milsom MD, Williams DA.

DNA Repair (Amst). 2007 Aug 1;6(8):1210-21. Epub 2007 May 7. Review.

5.

[Genetic therapy for hemophiliacs--therapeutic potential and technological limits].

Michou AI, Christ M, Pavirani A, Mehtali M.

Transfus Clin Biol. 1997;4(3):251-61. Review. French.

PMID:
9264782

Supplemental Content

Support Center